Pharmacy

 

Ardian to buy France’s largest pharmacy chain and make it multinational

French PE firm Ardian has entered into exclusive negotiations to buy France's largest pharmacy chain, Aprium Pharmacie, from North American PE firm Sagard. Ardian plans to develop Aprium's advisory and digital offering, and to expand the group outside of France. We speak to Ardian's head of growth to find out more.
January 26, 2024

Aster DM sells majority stake in Gulf business for $1bn

Dubai-based listed hospital and pharmacy chain Aster DM is selling a majority 65% stake in its Gulf business for a shade over $1bn to a consortium led by PE investor Fajr Capital. HBI investigates the thinking behind the deal, what this means for the group's expansion plans, and looks at the future of the GCC market generally with the help of expert commentary. 
December 1, 2023

Fresenius: “We’re not selling”

Germany-based healthcare conglomerate Fresenius tells HBI it isn't currently looking to carve off parts of its business for sale, and despite mixed H1 results it sees plenty of opportunities for growth.
August 5, 2022

HBI 2022: Balance of power in MENA is shifting

There is a risk, when looking at healthcare markets in MENA, of lumping all the countries together as one - but each market has very specific requirements, and very specific characteristics. A panel at HBI 2022 chaired by Hamid Yunis, partner at global law firm McDermott Will & Emery, investigated challenges and opportunities in the region - and how rapidly the markets are changing and why overseas players now need to work harder to impress.
July 1, 2022

Interview: Zeinab Ardeshir, CEO, PillSorted

Zeinab Ardeshir has worked in pharmacy for 17 years in multiple countries, but although she has generally enjoyed this experience, she found that a lot of her time was spent on mundane repetitive tasks which seemed like a waste for someone with her medical knowledge.
May 26, 2022

German government pushing ahead with cannabis legalisation

The German health minister is pressing ahead with plans to legalise cannabis, despite concerns from some quarters that it could be challenged at the EU level, and unresolved questions about what the regulatory framework will look like. HBI speaks to legal and policy experts, and hears that medical cannabis producers have an early adopter advantage against potential rivals - and there are health implications if legislation passes.
May 13, 2022

How can you build a successful health care science cluster in Europe?

Europe, with its often rigorous divides between research institutes and university hospitals, has fallen a long way behind power houses such as MIT/Harvard/Mass General in the generation of applied medical science. So how do you build a successful healthcare science cluster in Europe?
March 24, 2022
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us